174 related articles for article (PubMed ID: 35463214)
1. Clinical outcomes associated with expression of aurora kinase and p53 family members in muscle-invasive bladder cancer.
Burgess EF; Livasy C; Trufan S; Zhu J; O'Connor HF; Hartman A; Clark PE; Grigg C; Raghavan D
Mol Clin Oncol; 2022 May; 16(5):102. PubMed ID: 35463214
[TBL] [Abstract][Full Text] [Related]
2. High aurora kinase expression identifies patients with muscle-invasive bladder cancer who have poor survival after neoadjuvant chemotherapy.
Burgess EF; Livasy C; Trufan S; Hartman A; Guerreri R; Naso C; Clark PE; Grigg C; Symanowski J; Raghavan D
Urol Oncol; 2019 Dec; 37(12):900-906. PubMed ID: 31597600
[TBL] [Abstract][Full Text] [Related]
3. SIX3, a tumor suppressor, inhibits astrocytoma tumorigenesis by transcriptional repression of AURKA/B.
Yu Z; Sun Y; She X; Wang Z; Chen S; Deng Z; Zhang Y; Liu Q; Liu Q; Zhao C; Li P; Liu C; Feng J; Fu H; Li G; Wu M
J Hematol Oncol; 2017 Jun; 10(1):115. PubMed ID: 28595628
[TBL] [Abstract][Full Text] [Related]
4. Targeting aurora kinases as a potential prognostic and therapeutical biomarkers in pediatric acute lymphoblastic leukaemia.
Moreira-Nunes CA; Mesquita FP; Portilho AJS; Mello Júnior FAR; Maués JHDS; Pantoja LDC; Wanderley AV; Khayat AS; Zuercher WJ; Montenegro RC; de Moraes-Filho MO; de Moraes MEA
Sci Rep; 2020 Dec; 10(1):21272. PubMed ID: 33277547
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis identifies as a critical prognostic prediction gene in breast cancer.
Hu T; Wang X; Xia Y; Wu L; Ma Y; Zhou R; Zhao Y
Chin Med J (Engl); 2022 Sep; 135(18):2218-2231. PubMed ID: 36113844
[TBL] [Abstract][Full Text] [Related]
6. Quantitation of Aurora kinase A gene copy number in urine sediments and bladder cancer detection.
Park HS; Park WS; Bondaruk J; Tanaka N; Katayama H; Lee S; Spiess PE; Steinberg JR; Wang Z; Katz RL; Dinney C; Elias KJ; Lotan Y; Naeem RC; Baggerly K; Sen S; Grossman HB; Czerniak B
J Natl Cancer Inst; 2008 Oct; 100(19):1401-11. PubMed ID: 18812553
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in
Liao Y; Liao Y; Li J; Li J; Fan Y; Xu B
Cancer Manag Res; 2018; 10():3801-3808. PubMed ID: 30288111
[TBL] [Abstract][Full Text] [Related]
8. Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant state.
den Hollander J; Rimpi S; Doherty JR; Rudelius M; Buck A; Hoellein A; Kremer M; Graf N; Scheerer M; Hall MA; Goga A; von Bubnoff N; Duyster J; Peschel C; Cleveland JL; Nilsson JA; Keller U
Blood; 2010 Sep; 116(9):1498-505. PubMed ID: 20519624
[TBL] [Abstract][Full Text] [Related]
9. p53 deficiency enhances mitotic arrest and slippage induced by pharmacological inhibition of Aurora kinases.
Marxer M; Ma HT; Man WY; Poon RY
Oncogene; 2014 Jul; 33(27):3550-60. PubMed ID: 23955083
[TBL] [Abstract][Full Text] [Related]
10. Aurora-A expression is independently associated with chromosomal instability in colorectal cancer.
Baba Y; Nosho K; Shima K; Irahara N; Kure S; Toyoda S; Kirkner GJ; Goel A; Fuchs CS; Ogino S
Neoplasia; 2009 May; 11(5):418-25. PubMed ID: 19412426
[TBL] [Abstract][Full Text] [Related]
11. Daurinol Enhances the Efficacy of Radiotherapy in Lung Cancer via Suppression of Aurora Kinase A/B Expression.
Woo JK; Kang JH; Shin D; Park SH; Kang K; Nho CW; Seong JK; Lee SJ; Oh SH
Mol Cancer Ther; 2015 Jul; 14(7):1693-704. PubMed ID: 25882311
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Aurora A enhances radiosensitivity in selected lung cancer cell lines.
Liu N; Wang YA; Sun Y; Ecsedy J; Sun J; Li X; Wang P
Respir Res; 2019 Oct; 20(1):230. PubMed ID: 31647033
[TBL] [Abstract][Full Text] [Related]
13. Outcomes for Muscle-invasive Bladder Cancer with Radical Cystectomy or Trimodal Therapy in US Veterans.
Kumar A; Cherry DR; Courtney PT; Nalawade V; Kotha N; Riviere PJ; Efstathiou J; McKay RR; Karim Kader A; Rose BS; Stewart TF
Eur Urol Open Sci; 2021 Aug; 30():1-10. PubMed ID: 34337540
[TBL] [Abstract][Full Text] [Related]
14. Expression of aurora kinase A is associated with metastasis-free survival in node-negative breast cancer patients.
Siggelkow W; Boehm D; Gebhard S; Battista M; Sicking I; Lebrecht A; Solbach C; Hellwig B; Rahnenführer J; Koelbl H; Gehrmann M; Marchan R; Cadenas C; Hengstler JG; Schmidt M
BMC Cancer; 2012 Nov; 12():562. PubMed ID: 23186136
[TBL] [Abstract][Full Text] [Related]
15. Aurora-A affects radiosenstivity in cervical squamous cell carcinoma and predicts poor prognosis.
Ma Y; Yang J; Wang R; Zhang Z; Qi X; Liu C; Ma M
Oncotarget; 2017 May; 8(19):31509-31520. PubMed ID: 28404933
[TBL] [Abstract][Full Text] [Related]
16. Progression of Disease after Bacillus Calmette-Guérin Therapy: Refining Patient Selection for Neoadjuvant Chemotherapy before Radical Cystectomy.
Hensley PJ; Bree KK; Campbell MT; Alhalabi O; Kokorovic A; Miest T; Nogueras-Gonzalez GM; Gao J; Siefker-Radtke AO; Guo CC; Navai N; Dinney CP; Kamat AM
J Urol; 2021 Nov; 206(5):1258-1267. PubMed ID: 34184926
[TBL] [Abstract][Full Text] [Related]
17. Spindle assembly checkpoint gene expression in childhood adrenocortical tumors (ACT): Overexpression of Aurora kinases A and B is associated with a poor prognosis.
Borges KS; Moreno DA; Martinelli CE; Antonini SR; de Castro M; Tucci S; Neder L; Ramalho LN; Seidinger AL; Cardinalli I; Mastellaro MJ; Yunes JA; Brandalise SR; Tone LG; Scrideli CA
Pediatr Blood Cancer; 2013 Nov; 60(11):1809-16. PubMed ID: 23788275
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of the neutrophil-to-lymphocyte ratio in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomy.
Black AJ; Zargar H; Zargar-Shoshtari K; Fairey AS; Mertens LS; Dinney CP; Mir MC; Krabbe LM; Cookson MS; Jacobsen NE; Griffin J; Montgomery JS; Vasdev N; Yu EY; Xylinas E; Campain NJ; Kassouf W; Dall'Era MA; Seah JA; Ercole CE; Horenblas S; McGrath JS; Aning J; Shariat SF; Wright JL; Thorpe AC; Morgan TM; Holzbeierlein JM; Bivalacqua TJ; North S; Barocas DA; Lotan Y; Grivas P; Stephenson AJ; Shah JB; van Rhijn BW; Spiess PE; Daneshmand S; Sridhar SS; Black PC
Urol Oncol; 2020 Jan; 38(1):3.e17-3.e27. PubMed ID: 31676278
[TBL] [Abstract][Full Text] [Related]
19. The Aurora-Kinase A Phe31-Ile polymorphism as possible predictor of response to treatment in head and neck squamous cell carcinoma.
Baumann A; Buchberger AMS; Piontek G; Schüttler D; Rudelius M; Reiter R; Gebel L; Piendl G; Brockhoff G; Pickhard A
Oncotarget; 2018 Feb; 9(16):12769-12780. PubMed ID: 29560108
[TBL] [Abstract][Full Text] [Related]
20. Association of an aurora kinase a (AURKA) gene polymorphism with progression-free survival in patients with advanced urothelial carcinoma treated with the selective aurora kinase a inhibitor alisertib.
Necchi A; Pintarelli G; Raggi D; Giannatempo P; Colombo F
Invest New Drugs; 2017 Aug; 35(4):524-528. PubMed ID: 28155045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]